Cellular therapy conditioning regimens · 3 regimens
Cost vs Efficacy · 2 points
| Regimen | Biomarker | Cost/cycle ↓ | Cycle | PFS ↕ | OS ↕ | Est. cycles | Course cost ↕ | Evidence |
|---|---|---|---|---|---|---|---|---|
Cyclophosphamide and Fludarabine (FC) Variant #15 | — | R 192 642 | — | ~20.6 mo | ~37.0 mo | — | — | 4 |
Cytarabine and Etoposide (CYVE) Variant #06 | — | R 11 761 | — | — | ~9.2 mo | — | — | — |
Bendamustine monotherapy Variant #01 | — | R 5 419 | — | ~16.5 mo | — | — | — | 2 |
3 of 3 regimens shown